YOLFTbeta
41

Microbio Co Ltd

4128 · TWO · Consumer Defensive / Packaged Foods

14.50TWD+1.25 (+9.43%)

Price History

Full chart

Market Stats

Previous Close13.25
Open13.45
Day Range13.40 – 14.55
52-Week Range13.60 – 22.80
Volume3.09M
Market Cap9.00B
P/E (TTM)17.19
Forward P/E1111.11
EPS0.89
Dividend Yield0.00%
Beta0.46
50-Day Avg14.79
200-Day Avg16.55

About

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of technology development, transfer, and consulting services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Tzen-Wen Chen
  • Employees0
  • HeadquartersNo. 3, Yuanqu Street, Taipei, Taiwan, Taiwan
  • Websitehttps://www.twmicrobio.com

Leadership

  • Mr. Tzen-Wen ChenGM & Chairman
  • Ms. Ying-Jun WangAccounting Supervisor & Associate of Finance Department
  • Ms. Wan-Jiun ChenDeputy General Manager of R&D Center
  • Ms. Ya-Lin WengAssistant Vice President of Production Department
  • Ms. Fu-Chiao HuangAssistant Vice President of the Business Department, Department of Pharmaceuticals
  • Mr. William LuFounder
  • Sweet WongPresident of Investment
  • Ms. Chieh-Chen LinAssistant Vice President of Sustainable Development Team

Financials

Income Statement

Currency: TWD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue231.53M155.60M512.59M737.67M1.08B1.19B1.18B1.17B1.40B1.52B1.52B1.41B1.45B1.47B1.60B1.78B1.72B1.59B1.72B1.89B
Growth (%)--32.79%+229.42%+43.91%+46.29%+10.72%-1.43%-0.83%+19.82%+8.54%+0.24%-7.20%+2.53%+1.23%+9.21%+11.28%-3.38%-7.58%+8.26%+9.94%
Cost of Revenue127.66M83.56M287.42M405.68M522.19M596.32M670.67M706.55M829.30M943.61M941.62M891.87M877.98M886.25M967.67M1.04B1.03B1.21B1.05B1.14B
Gross Profit103.87M72.05M225.17M332.00M556.93M598.47M506.99M461.29M570.05M575.25M580.82M520.92M570.55M580.06M633.73M739.37M691.29M380.42M676.08M753.46M
Gross Margin44.86%46.30%43.93%45.01%51.61%50.09%43.05%39.50%40.74%37.87%38.15%36.87%39.39%39.56%39.57%41.49%40.15%23.90%39.24%39.78%
Operating Expense112.20M171.83M367.17M466.16M761.62M981.65M938.04M870.29M957.60M917.85M850.25M766.49M703.03M825.05M106.98M965.02M533.37M886.89M1.13B1.16B
Operating Income-8.33M-99.78M-142.00M-134.16M-204.70M-383.19M-431.06M-409.01M-387.54M-342.61M-269.43M-245.57M-132.48M-244.99M526.75M-225.65M157.92M-506.47M-451.14M-406.62M
Operating Margin-3.60%-64.13%-27.70%-18.19%-18.97%-32.07%-36.60%-35.02%-27.69%-22.56%-17.70%-17.38%-9.15%-16.71%32.89%-12.66%9.17%-31.83%-26.19%-21.47%
EBITDA15.23M-89.37M-115.64M-64.27M-138.13M-17.86M-253.43M-50.67M-158.13M-141.83M-225.12M584.41M-661.74M-54.89M738.86M44.55M400.40M-261.31M-1.00B-665.16M
EBITDA Margin6.58%-57.44%-22.56%-8.71%-12.80%-1.49%-21.52%-4.34%-11.30%-9.34%-14.79%41.37%-45.68%-3.74%46.14%2.50%23.25%-16.42%-58.14%-35.12%
Net Income-24.09M-123.43M25.94M-81.77M412.53M280.37M-33.29M-129.12M-140.43M-193.69M-267.81M543.03M-690.74M-264.60M519.84M-233.16M152.42M-1.18B-1.10B-757.75M
Net Income Margin-10.40%-79.32%5.06%-11.08%38.23%23.47%-2.83%-11.06%-10.04%-12.75%-17.59%38.44%-47.69%-18.05%32.46%-13.08%8.85%-74.14%-63.89%-40.01%
R&D24.71M25.89M59.50M87.59M136.68M132.29M165.60M241.29M231.61M178.14M181.88M87.60M40.10M98.16M352.97M861.54M264.91M404.49M388.66M366.71M
R&D as % of Total Revenue10.67%16.64%11.61%11.87%12.67%11.07%14.06%20.66%16.55%11.73%11.95%6.20%2.77%6.69%22.04%48.35%15.39%25.42%22.56%19.36%
Interest Expense7.17M10.88M15.68M6.96M5.08M1.38M1.11M8.03M2.08M7.05M7.07M6.79M2.83M9.47M7.33M6.22M6.10M7.38M10.13M11.72M
Interest Expense % of Total Revenue3.10%6.99%3.06%0.94%0.47%0.12%0.09%0.69%0.15%0.46%0.46%0.48%0.20%0.65%0.46%0.35%0.35%0.46%0.59%0.62%

Balance Sheet

Currency: TWD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets801.18M1.74B2.27B5.90B5.53B6.65B7.26B9.54B9.75B9.83B9.26B9.16B10.23B10.05B13.93B15.02B15.09B14.74B13.93B12.33B
Total Liabilities241.78M443.47M473.77M638.68M494.42M411.80M942.47M834.06M645.86M889.40M844.17M859.50M555.11M1.01B1.07B1.17B1.08B1.23B2.06B2.13B
Total Equity559.36M1.29B1.44B4.35B4.75B5.04B5.00B7.38B7.76B7.65B7.23B7.72B7.33B6.71B10.63B11.89B12.09B11.81B10.31B8.91B
Cash237.35M1.14B1.35B4.22B3.99B4.03B3.78B2.56B653.69M718.15M1.28B1.17B2.38B1.30B679.66M725.71M1.13B635.81M673.28M711.13M
Total Debt152.10M307.42M285.84M409.57M106.74M32.40M603.56M450.76M250.81M503.32M510.88M503.45M150.08M660.16M508.66M519.30M490.28M621.34M--
Net Debt-85.24M-834.01M-1.06B-3.81B-3.89B-4.00B-3.18B-2.11B-402.89M-214.84M-767.49M-670.57M-2.23B-641.00M-171.00M-206.40M-641.79M-14.46M--

Cash Flow

Currency: TWD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow4.39M-95.30M-143.21M-485.10M520.41M-271.95M-132.36M-176.63M-167.04M-161.90M-180.25M-9.83M15.85M72.36M109.82M53.98M141.57M-78.15M529.90M85.27M
Investing Cash Flow----------23.56M768.50M-197.18M-528.98M-712.01M-591.58M7.60M334.56M---
Financing Cash Flow134.74M1.03B299.37M3.66B297.79M634.46M611.15M2.24B443.60M261.37M1.93M110.27M1.74B-338.47M-172.89M-42.19M-67.12M-155.98M--
Capital Expenditure15.05M35.90M153.42M67.46M119.59M360.41M208.18M299.55M197.94M154.64M45.32M29.72M296.56M292.36M79.83M103.96M43.12M48.04M40.24M69.22M
Free Cash Flow-10.66M-131.20M-296.63M-552.56M400.83M-632.36M-340.54M-476.18M-364.98M-316.54M-225.57M-39.55M-280.71M-220.00M29.98M-49.98M98.45M-126.19M489.67M16.05M
Dividends Paid---29.86M-67.31M27.40M------18.65M18.65M18.65M18.65M20.44M--
FCF to OCF-243.05%137.67%207.13%113.91%77.02%232.53%257.28%269.59%218.50%195.52%125.14%402.33%-1771.17%-304.04%27.30%-92.59%69.54%161.48%92.41%18.83%
Dividend Paid to FCF----5.40%--10.64%-8.05%-------8.48%62.21%-37.32%18.95%-16.20%--

Earnings

Report DateApr 29, 2008Oct 30, 2008Aug 30, 2011Jan 15, 2012Nov 12, 2013Mar 25, 2014Aug 14, 2014Nov 10, 2014May 11, 2015
EPS Estimate-0.02-0.230.07-0.17-0.16-0.13-0.11-0.09-0.02
EPS Actual-0.12-0.030.01-0.12-0.06-0.11-0.07-0.04-0.13
Surprise-500.00%86.96%-85.71%29.41%62.50%15.38%36.36%55.56%-550.00%
TimingAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap9.00B
Enterprise Value6.61B
Trailing P/E17.19
Forward P/E1111.11
Price / Sales4.58
Price / Book0.92
EPS0.89
Book Value16.15
Revenue (TTM)1.97B
Gross Profit (TTM)778.39M
EBITDA-370.61M
Profit Margin26.62%
Operating Margin-32.08%
Return on Equity2.48%
Return on Assets-2.33%
Shares Outstanding588.17M
Shares Float422.88M
Beta0.46
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.04Jun 16, 2023
20221×
0.03Jul 18, 2022
20121×
0.05Aug 28, 2012
20111×
0.14Jul 19, 2011
20091×
0.09Jul 22, 2009

Stock Splits

  • Aug 29, 20241050:1000
  • Jun 16, 20231098108:1000000
  • Jul 18, 20221096:1000
  • Sep 28, 20211098.203:1000
  • Aug 27, 20131.0401:1
  • Aug 28, 20121.19:1
  • Jul 19, 20111.2198:1